Wall Street is forecasting a better backdrop for companies that want to go public.
While lower rates can stoke the IPO market, fewer rate cuts because the economy remains strong with cooling inflation should still be viewed as favorable.
The IPO market and mergers and acquisitions (M & A) activity started to sour when the Fed began hiking interest rates back in March 2022.
A strong IPO market overall is expected to also benefit burgeoning biotechnology firms, which would mean more business for Danaher.
As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade.
Persons:
That's, Goldman Sachs, Goldman, Morgan Stanley, Danaher, Morgan, Morgan Stanley didn't, Ted Pick's, Jim Cramer, Morgan Stanley's, Raymond James, —, Jim Cramer's, Jim, Brendan Mcdermid
Organizations:
Federal, stoke, UST, Goldman, Fed, Companies, IB, Danaher, Biotech, Silicon Valley Bank, CNBC, Traders, New York Stock Exchange
Locations:
U.S, Silicon